Journey Medical Corporation (DERM) NASDAQ

7.13

+0.006(+0.08%)

Updated at October 01 10:53AM

Currency In USD

Journey Medical Corporation

Address

9237 East Via de Ventura Boulevard

Scottsdale, AZ 85258

United States of America

Phone

480 434 6670

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

41

First IPO Date

November 12, 2021

Key Executives

NameTitlePayYear Born
Mr. Claude MaraouiFounder, President, Chief Executive Officer & Director975,4341967
Dr. Lindsay Allan RosenwaldExecutive Chairman50,0001955
Mr. Joseph M. BeneschChief Financial Officer & Corporate Controller434,0881967
Mr. Louis DonatiDirector of Market Access0N/A
Jaclyn JaffeSenior Director of Corporate Operations0N/A
Mr. Ramsey AlloushChief Operating Officer, General Counsel & Company Secretary01986
Mr. Robert NevinChief Commercial Officer01969

Description

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.